AWAK Attracts Investment Billions
Singapore-based AWAK Technologies’ miniaturized sorbent platform for PD and HD regenerates dialysate to use up to 90% less fluid. This package was intriguing enough to attract an $11.2B investment from Accuron MedTech—improving its changes of reaching the market!
Read the full article » | Posted 06-12-2017
Related Articles
- HD with Saline and No Blood Thinner? Posted 06-11-2025
- AWAK is now Singapore-based Vivance Posted 05-20-2025
- Archimedes by Simergent Promises Quieter, Less Painful APD Posted 05-20-2025
- PeritoneX by Relavo Medical Posted 05-20-2025